Recursion - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRecursion
Recursion logo

Recursion

0 followers

RXRX

Performance

About Recursion

Recursion is a biotechnology company leveraging AI-driven drug discovery to decode biology and accelerate the development of new medicines. By imaging cells and training machine learning models on phenomics, transcriptomics, and other omics data, they aim to shorten hit identification to IND-enabling studies and improve success rates in areas like oncology and rare diseases. The company operates from Salt Lake City, Utah, and emphasizes its Recursion Operating System and partnerships with pharma and tech leaders to advance faster, cost-efficient drug development.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Erica Fox

Chief People and Impact Officer

Nathan Hatfield, MBA, J.D.

Chief Legal Officer & Corporate Secretary

David Mauro, M.D., Ph.D.

Chief Medical Officer

Najat Khan, Ph.D.

CEO and President

Ryan Kelly

Chief Communications Officer

Key Facts

HQ Location

Salt Lake City, United States

Founded

2009

Employees

501-1K

Status

Public

Website

https://recursion.com